DisclosureWe earn commission on partner links; ranking is set by clinician-vetted methodology — not advertisers.
Insulin resistance is a condition in which the body's cells—mainly in the muscles, fat, and liver—stop responding well to insulin, the hormone that helps move glucose (blood sugar) from the bloodstream into cells for energy. When cells resist insulin's signal, glucose builds up in the blood. To compensate, the pancreas releases more insulin (a state called hyperinsulinemia). For a time this keeps blood sugar in the normal range, but over years the pancreas may not keep up, allowing blood glucose to rise into the prediabetes and then type 2 diabetes range.
Insulin resistance is the underlying driver of prediabetes and most type 2 diabetes, and it sits at the center of metabolic syndrome—a cluster of conditions (high blood pressure, high triglycerides, low HDL cholesterol, elevated blood sugar, and excess waist fat) that together raise the risk of heart disease and stroke.
Researchers do not fully understand the exact cause of insulin resistance, but several factors clearly raise the risk. According to the CDC and NIDDK, these include:
Importantly, you do not have to be overweight to have insulin resistance, and not everyone with overweight develops it.
Most people with insulin resistance and prediabetes have no symptoms at all, which is why it often goes undetected for years. You cannot tell whether someone has insulin resistance simply by looking at them.
When physical signs do appear, they may include:
Because symptoms are usually absent, screening with blood tests is the only reliable way to identify the problem early.
In everyday practice, clinicians do not measure insulin resistance directly. Instead, they assess blood glucose and related risk factors. The three standard blood tests and their prediabetes ranges (per NIDDK) are:
Results at or above the upper end of these ranges (A1C 6.5% or higher, fasting glucose 126 mg/dL or higher, or 2-hour value 200 mg/dL or higher) indicate diabetes. Clinicians may also check triglycerides, HDL cholesterol, and blood pressure to evaluate metabolic syndrome. Research tools such as the HOMA-IR index exist but are used mainly in studies rather than routine care.
The U.S. Preventive Services Task Force and CDC support screening adults age 35 to 70 who have overweight or obesity, and earlier or more often for those with additional risk factors. People found to have prediabetes are generally retested for diabetes every year.
The strongest evidence for reversing or improving insulin resistance comes from lifestyle change, supported by selected medications.
Lifestyle modification (first-line). In the landmark Diabetes Prevention Program (DPP), a structured lifestyle program reduced the development of type 2 diabetes by 58% over about three years—more effective than medication. The program's goals were at least 7% weight loss and at least 150 minutes per week of moderate activity such as brisk walking. Long-term follow-up showed these benefits persisted for many years. Even modest weight loss of about 5% to 7% meaningfully lowers risk.
Medication. In the same trial, metformin lowered diabetes risk by about 31%. Metformin is sometimes prescribed for prediabetes, particularly in younger adults, those with higher A1C, or people with a history of gestational diabetes, though it is not FDA-approved specifically for prediabetes. Other glucose-lowering and weight-management therapies may be considered by a clinician depending on the individual. All medications carry potential side effects and require medical supervision.
Talk with a healthcare professional about testing if you are 35 or older, have overweight or obesity plus another risk factor, have a family history of diabetes, had gestational diabetes or PCOS, or notice signs such as acanthosis nigricans. Seek prompt care for symptoms of high blood sugar—increased thirst, frequent urination, unexplained weight loss, blurred vision, or fatigue. If you already have prediabetes, ask about a CDC-recognized Diabetes Prevention Program and yearly diabetes testing.
*This article is for general information and education only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider about your individual situation.*
No medication is FDA-approved specifically to treat "insulin resistance" as a standalone diagnosis. The strongest evidence-based intervention is structured lifestyle change—about 7% weight loss and at least 150 minutes of weekly physical activity—which reduced progression to type 2 diabetes by 58% in the NIH Diabetes Prevention Program. Metformin (FDA-approved for type 2 diabetes) is sometimes used off-label for prediabetes and reduced diabetes risk by 31% in the same trial; it should only be taken under a clinician's supervision. Other glucose-lowering or weight-management medications may be appropriate for some individuals and should be discussed with a healthcare provider. Be cautious with unregulated supplements marketed to "reverse insulin resistance," as these are not FDA-approved for this use and generally lack rigorous evidence.
This page is for general information and is not medical advice. Always consult a qualified clinician about diagnosis and treatment. Individual results vary.